237
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Application of active layering and coating techniques in the development of a multiparticulate, controlled release dosage form of a high-dose, highly soluble drug

, , , &
Pages 556-564 | Received 06 May 2013, Accepted 07 May 2013, Published online: 14 Jun 2013

References

  • Breimer DD. Future challenges for drug delivery. J Control Release 1999;62:3–6
  • Jones DM. Solution and suspension layering. In: Ghebre Sellassie I, ed. Pharmaceutical pelletization technology. New York: Marcel-Dekker; 1989:145–164
  • Sinchaipanid N, Chitropas, P, Mitrevej A. Influences of layering on theophylline pellet characteristics. Pharm Dev Technol 2004;9:163–170
  • Baki G, Bajdik J, Djuric D, et al. Role of surface free energy and spreading coefficient in the formulation of active agent-layered pellets. Eur J Pharm Biopharm 2010;74:324–331
  • Suhrenbrock L, Radtke G, Knop K, Kleinebudde P. Suspension pellet layering using PVA-PEG graft copolymer as a new binder. Int J Pharm 2011;412:28–36
  • Iyer RM, Augsburger LL, Parikh DM. Evaluation of drug layering and coating: effect of process mode and binder level. Drug Dev Ind Pharm 1993;19:981–998
  • Rashid HA, Heinämäki J, Antikainen OK, Yliruusi JK. Povidone and maltodextrin as binders for the preparation of drug-layered pellets based on microcrystalline cellulose beads using centrifugal granulating process. STP Pharm Sci 2000;10:355–362
  • Nikowitz K, Kasa P, Pintye-Hodi K, Regdon G. Study of the preparation of a multiparticulate drug delivery system with a layering technique. Powder Technol 2011;205:155–159
  • Kolter K, Gotsche M, Schneider T. Physicochemical characterization of Kollicoat® IR. BASF ExAct 2002;8:2–3
  • Strüebing S, Metz H, Syrowatka F, Maeder K. Monitoring of dissolution induced changes in film coat composition by 1H NMR spectroscopy and SEM. J Control Rel 2007;119:190–196
  • Strüebing S, Metz H, Maeder K. Mechanistic analysis of drug release from tablets with membrane controlled drug delivery. Eur J Pharm Biopharm 2007;66:113–119
  • Romer M, Heinamaki J, Strachan C, et al. Prediction of tablet film-coating thickness using a rotating plate coating system and NIR spectroscopy. AAPS PharmSciTech 2008;9:1047–1053
  • Ensslin S, Moll KP, Metz H, et al. Modulating pH-independent release from coated pellets: effect of coating composition on solubilization processes and drug release. Eur J Pharm Biopharm 2009;72:111–118
  • Muschert S, Siepmann F, Leclercq B, et al. Drug release mechanisms from ethylcellulose: PVA-PEG graft copolymer-coated pellets. Eur J Pharm Biopharm 2009;72:130–137
  • Kolter K, Ruchatz F. Kollicoat® SR 30 D: a new sustained release excipient. BASF ExAct 1998;3:2–3
  • Dashevsky A, Wagner K, Kolter K, Bodmeier R. Physicochemical and release properties of pellets coated with Kollicoat SR 30 D, a new aqueous polyvinyl acetate dispersion for extended release. Int J Pharm 2005;290:15–23
  • Dashevsky A, Ahmed AR, Mota J, et al. Effect of water-soluble polymers on the physical stability of aqueous polymeric dispersions and their implications on the drug release from coated pellets. Drug Dev Ind Pharm 2010;36:152–160
  • Cuppoka Y, Muschert S, Marucci M, et al. Drug release mechanisms from Kollicoat SR:Eudragit NE coated pellets. Int J Pharm 2011;409:30–37
  • Dreu R, Lüstrik M, Perpar M, et al. Fluid-bed coater modifications and study of their influence on the coating process of pellets. Drug Dev Ind Pharm 2012;38:501–511
  • Lüstrik M, Dreu R, Sibanc R, Srcic S. Comparative study of the uniformity of coating thickness of pellets coated with a conventional Wurster chamber and a swirl generator-equipped Wurster chamber. Pharm Dev Technol 2011;17:268–276
  • Vuppala MK, Parikh DM, Bhagatt HR. Application of powder-layering technology and film coating for manufacture of sustained-release pellets using a rotary fluid bed processor. Drug Dev Ind Pharm 1997;23:687–694
  • Nastruzzi C, Cortesi R, Esposito E, et al. Influence of formulation and process parameters on pellet production by powder layering technique. AAPS PharmSciTech 2000;1:Article 9
  • Patel NV, Patel JK, Shah SH, Patel JN. Central composite design for the formulation and optimization of a multi-unit potential colonic drug delivery system of budesonide for ulcerative colitis. Pharmazie 2011;66:124–129
  • FDA Guidance for Industry. Dissolution testing of immediate release solid oral dosage forms; 1997
  • Costa P, Sousa Lobo JM. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–133
  • Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspensions. J Pharm Sci 1961;50:874–875
  • Higuchi T. Mechanisms of sustained action mediation. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices. J Pharm Sci 1963;52:1145–1149
  • Hamed H, Sakr A. Effect of curing conditions and plasticizer level on the release of highly lipophilic drug from coated multiparticulate drug delivery system. Pharm Dev Technol 2003;8:397–407
  • Kim M-S, Kim J-S, You Y-H, et al. Development and optimization of a novel oral controlled delivery system for tamsulosin hydrochloride using response surface methodology. Int J Pharm 2007;341:97–104
  • Kibria G, Roni MA, Absar MS, Jalil R. Effect of plasticizer on release kinetics of diclofenac sodium pellets coated with Eudragit RS 30 D. AAPS PharmSciTech 2008;9:1240–1246
  • Pinto JF, Podczeck F, Newton JM. The use of statistical moment analysis to elucidate the mechanism of release of a model drug from pellets produced by extrusion and spheronization. Chem Pharm Bull 1997;45:171–180
  • Guns S, Kayaert P, Martens JA, et al. Characterization of the copolymer poly(ethyleneglycol-g-vinylalcohol) as a potential carrier in the formulation of solid dispersions. Eur J Pharm Biopharm 2010;74:239–247
  • AlKhatib HS, Hamed S, Najjar S, et al. Effects of thermal curing conditions on drug release from polyvinyl acetate – polyvinyl pyrrolidone matrices. AAPS PharmSciTech 2010;11:253–266
  • Gonzalez Novoa GA, Heinämäki J, Mirza S, et al. Physical solid-state properties and dissolution of sustained-release matrices of polyvinylacetate. Eur J Pharm Biopharm 2005;59:343–350

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.